Day: September 2, 2020

OMAHA, Neb., Sept. 02, 2020 (GLOBE NEWSWIRE) — Beginning Monday, August 31, 2020, northbound and southbound traffic on Highway 50 (144th Street) in the vicinity of Interstate 80 will be restricted to one lane each way with periodic lane shifts. This traffic pattern is scheduled to last into December 2020.Midwest DCM, of Omaha, Nebraska, has the roadway construction contract. The lane restrictions and shifts are necessary for the construction of additional traffic lanes and turn lanes in the area to improve traffic conditions for motorists.Motorists should expect delays in this area and are encouraged to utilize alternate routes if possible. Motorists are also asked to drive cautiously in and near work zones, to buckle up and to put cell phones down.Fred Thayer, Associate Vice President – Corporate Brand and CommunicationsWerner...

SOUTH JORDAN, Utah, Sept. 02, 2020 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate at four conferences in September.On Wednesday, September 9, Merit’s Chairman and Chief Executive Officer Fred P. Lampropoulos and Chief Financial Officer Raul Parra will host one-on-one virtual meetings throughout the day at the 13th Annual Barrington Research Virtual Fall Investment Conference.On Thursday, September 10, Mr. Lampropoulos will host one-on-one virtual meetings throughout the day at the 2020 Wells Fargo Virtual Healthcare Conference.On Thursday, September 10, Mr. Parra will...

BILLERICA, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and members of the Company’s executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference taking place September 9-10, 2020, in one-on-one meetings.About Conformis, Inc.Conformis is a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which we refer to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy.  Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory...

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced that the Company will participate in the following upcoming virtual investor conferences in September:Asa Abeliovich, M.D., Ph.D., Founder and Chief Executive Officer of Prevail, will participate in a panel presentation at the Citi 15th Annual BioPharma Conference on Thursday, September 10 at 3:20 p.m. ET. The panel is titled “Disease-Modifying Therapies for Neurodegenerative Diseases.” Dr. Abeliovich will participate in a fireside chat at the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September 14 at 12 p.m. ET. Dr. Abeliovich will participate in a fireside chat at the Cantor...

GAITHERSBURG, Md., Sept. 02, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the publication in The New England Journal of Medicine of Phase 1 data from its Phase 1/2 clinical trial of NVX‑CoV2373, its COVID‑19 vaccine candidate adjuvanted with Matrix‑M™, in healthy adults 18-59 years of age. The publication offers further detail on the previously announced results, in which NVX‑CoV2373 demonstrated a reassuring safety and reactogenicity profile and induced robust antibody responses numerically superior to that seen in human convalescent sera. The manuscript is available at https://www.nejm.org/doi/full/10.1056/NEJMoa2026920?query=featured_coronavirus.“The rapid publication of Phase 1 results from our trial...

LIVERMORE, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ:FORM), a leading semiconductor test and measurement supplier, today introduced the CM300xi-ULN , a 300mm wafer probe system designed for highly accurate testing of flicker noise (1/f), random telegraph noise (RTN), and phase noise. These noise phenomena increasingly plague advanced analog and digital IC technologies, whose power and performance gains come at a cost of reduced noise tolerance. Thus, device design and validation now require careful characterization of these internal noise sources using highly sensitive equipment. By eliminating over 97% of the environmental noise experienced in previous probe systems, the CM300xi-ULN system establishes a new industry gold standard for the ultra-low noise measurement.“The new CM300xi-ULN with Contact Intelligence...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES.VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) — Trillium Gold Mines Inc. (“Trillium” or the “Company”) (TSXV: TGM) is pleased to announce that in connection with its previously announced brokered private placement, the Company and Eight Capital have agreed to increase the size of the offering, subject to all required regulatory approvals. Trillium will now issue 2,294,200 units (the “Units”) at an offering price of $1.70 per Unit; 1,631,600 flow-through common shares (the “FT Shares”) at an offering price of $1.90 per FT Share; and 2,479,400 charity flow-through units (the “Charity FT Units”) at an offering price of $2.42 per Charity FT Unit, for aggregate gross proceeds of $13,000,328.Each Unit will be comprised of one common share...

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Cartier Iron Corporation (CSE: CFE) (“Cartier Iron” or the “Company”) is pleased to report that, further to its announcement made earlier in the day, it is increasing its non-brokered private placement (the “Private Placement”) from 12,5000,000 units at $0.07 (“Units”) to 15,000,000 Units at $0.07, for proceeds of up to $1,050,000. As reported earlier, the Private Placement has a lead order from Palisades Goldcorp Ltd. (“Palisades Goldcorp”).Each Unit will consist of one common share in the capital of Cartier Iron (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one Common Share at a price of $0.10 per share for a term of 36 months following the closing of the Private Placement.The net proceeds of the Private Placement...

MARIETTA, Ga., Sept. 02, 2020 (GLOBE NEWSWIRE) — BlueLinx Holdings Inc. (NYSE: BXC), a leading distributor of building and industrial products in the United States, today announced that it filed an amendment to update an exhibit to the universal shelf registration statement on Form S-3 that it filed in November 2019. Following review of the amendment by the U.S. Securities and Exchange Commission (SEC), the Company intends to request that the shelf registration statement be declared effective.The Company did not actively pursue effectiveness of the shelf registration statement after its initial filing with the SEC, and the Company was recently notified by the SEC that pursuant to its rules, given the passage of time since its filing, the shelf registration statement would be deemed abandoned if the Company did not request that it...

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) announced today that it has closed an offering of $6 billion senior unsecured notes, comprised of the following tranches (collectively, the “Notes”):$1 billion aggregate principal amount of 0.75% Senior Notes due 2023;$1 billion aggregate principal amount of 1.20% Senior Notes due 2025;$1 billion aggregate principal amount of 1.75% Senior Notes due 2027;$1 billion aggregate principal amount of 2.20% Senior Notes due 2030;$1 billion aggregate principal amount of 3.30% Senior Notes due 2040; and$1 billion aggregate principal amount of 3.55% Senior Notes due 2050.The Notes were issued in a private offering exempt from registration in accordance with Rule 144A and Regulation S under the Securities Act of 1933, as amended (the “Securities Act”). The Notes are...